Top California Biotech Companies (1,044)
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is using the power of high-intensity sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop and commercialize pioneering products.
GRAIL's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue is rising across 2025 and into 2026, with Galleri driving year-over-year increases and volumes outpacing revenue. Feedback suggests growth accelerated in early 2026 as test adoption broadened.
Strategic Partnerships: Partnerships such as Epic EHR integration and a collaboration with Samsung for Asia expansion are expanding distribution and market access. These relationships also support commercialization through employers, health systems and digital-health channels.
Investor Backing & Capital Strength: A sizable cash balance and recent equity financing provide a substantial runway to fund R&D and commercial expansion. This capital position helps buffer the costs of scaling while regulatory review proceeds.
We bring together one of the world’s largest libraries of multimodal clinical and molecular data with a robust suite of AI tools to help physicians personalize care in real time, connect patients with therapies and clinical trials, and enable partners to accelerate discovery and development of new treatments. With ~8 million de-identified research records and 350+ petabytes of data, Tempus partners...
Tempus AI's Top Stability & Growth Strengths
Strong Revenue Growth: Recent financial results highlight sustained top-line expansion with rising quarterly revenue and management increasing full‑year guidance, indicating momentum across 2025 and into 2026.
Diversified Revenue Streams: Growth is coming from both diagnostics and data licensing/AI applications, with testing volumes and data contracts expanding rather than reliance on a single line of business.
Customer Loyalty & Retention: Reported net revenue retention above 100% and sizable remaining contract value suggest existing pharmaceutical customers are deepening engagements.
OmniCable is a premier redistributor of wire and cable, electrical products, and value-added services. OmniCable empowers our industry to be successful by providing an exceptional experience through operational excellence, accuracy and precision, and a partnership approach. With a multi-million dollar inventory and the acquisition of Houston Wire & Cable, we offer distributors products from the industry’s leading manufacturers. Since our...
OmniCable's Top Stability & Growth Strengths
Market Expansion: The acquisition of Kingwire added eight warehouses and extended reach into utility, data center, industrial, and renewable-energy markets, while multiple 2026 sales-agent agreements broadened coverage across additional U.S. territories. A new 285,000+ sq. ft. Georgia distribution center and other facility upgrades further support a wider geographic footprint.
Product Line Growth: A dedicated Communications Business Unit and expanded aluminum building wire capabilities via Kingwire broaden the portfolio beyond traditional electrical wire into fiber, broadband, and industrial-automation offerings. Added supplier agreements, such as with Dura-Line and Lynn Networks, deepen communications and connectivity products.
Strategic Partnerships: New and expanded sales-agent relationships (e.g., Blue Sky Reps, Electrical Lines, DSI Southwest, Rowe Sales) extend local market reach without requiring new branches. Manufacturer partnerships and designations enhance channel access and assortment across broadband and communications categories.
Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. The predictive power of Schrödinger's software allows scientists to accelerate their research and development, reduce research costs, and make novel discoveries.
Schrödinger, Inc.'s Top Stability & Growth Strengths
Strong Revenue Growth: Revenue expanded on an annual basis and continued to rise into 2026, while software annual contract value increased, indicating underlying demand. Drug discovery contributions and growing software contract activity supported the top line despite timing effects in reported software revenue.
Strategic Partnerships: Collaborations with major pharmaceutical companies and acquisition-related milestones added material revenue and visibility. These relationships complement the software business and reinforce commercial traction across discovery programs.
Investor Backing & Capital Strength: A sizable cash and securities position at mid-2026 provides runway to fund operations and product transitions. Management’s multi‑year profitability targets suggest the balance sheet can support continued investment while losses narrow.
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for...
Pfizer's Top Stability & Growth Strengths
Product Line Growth: Newer and acquired medicines grew 18% operationally in Q2 2026, while revenue excluding Comirnaty and Paxlovid rose 5% operationally in the same period. Excluding COVID products, 2025 revenue also increased 6% operationally, supported by growth in products such as Eliquis and Padcev.
Cost & Operational Efficiency: Management is pursuing additional savings to improve operational efficiency and support profitability. These cost-control efforts are intended to help the business transition away from pandemic-driven sales while supporting margins.
Innovation-Driven Growth: Investment in future growth includes $10.4 billion in internal R&D during 2025 and ongoing development in oncology and obesity. A broad pipeline and recent acquisitions are intended to offset declining COVID-19 sales and patent expirations if programs succeed.
Biotechnology is rewriting life as we know it, from the medicines we take, to the crops we grow, and the household goods that we rely on every day. But moving at the new speed of science requires better technology. Benchling’s mission is to unlock the power of biotechnology. The world’s most innovative biotech companies use Benchling’s R&D Cloud to power the...
Benchling's Top Stability & Growth Strengths
Strong Revenue Growth: Evidence points to ARR reaching about $210M with continued year-over-year increases, and company statements indicate surpassing $200M in annualized revenue. Feedback suggests upselling and higher average revenue per customer support expansion from existing accounts.
Market Expansion: Adoption reportedly grew from ~410 customers in 2020 to 1,200+ by 2024, with 240 new customers added in 2024 and penetration into top-50 global biopharma firms. Feedback suggests partnerships and geographic breadth bolster reach across biotech and pharma.
Innovation-Driven Growth: Product launches in AI, automation, and broader R&D workflows, plus acquisitions and collaborations (e.g., Lilly TuneLab, NVIDIA) indicate active investment in next-generation capabilities. Feedback suggests these moves expand use cases and deepen platform integration in labs.
Rezo is a different kind of biopharma company. Our mission is to dramatically increase the success rate of drug development by building a disease-agnostic, fully-integrated, network biology platform that will redefine our understanding of human disease and ability to treat it. Our Founders and members of the Board are a group of esteemed, world-class scientists from the University of California,...
Every Exelixis employee is united in an ambitious cause: to launch innovative medicines that give patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. After operating in the challenging biotech sector for more than 25 years, we have a proven track record of resiliency in the face of adversity....
Exelixis's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results and guidance indicate year-over-year revenue increases with momentum in early 2026 and a higher full-year outlook. Product sales from the cabozantinib franchise are the primary driver, with ex‑U.S. royalties contributing.
Strong Market Position & Advantage: Cabozantinib serves as a cornerstone TKI in RCC, with a guideline‑preferred first‑line combination and a multi‑indication label supporting durable commercial scale. Disclosures describe leadership within the U.S. RCC oral TKI segment and sustained global uptake through partners.
Future-Ready Strategy: Multiple pivotal studies and an FDA‑accepted NDA for zanzalintinib establish a path to a second commercial pillar beyond RCC. Investments in GI commercial infrastructure and 2026 data milestones reinforce preparedness for the next phase of growth.
In a vast, unexplored virtual chemical space, Deep Apple Therapeutics moves with unprecedented speed to discover novel small molecules for high-value targets. Deep Apple combines ensemble cryo-EM to explore receptor conformations; deep learning; and the docking of multi-billion compound libraries generated using the company's proprietary Orchard.ai™ algorithm. Deep Apple's deep learning discovery engine is built upon founder expertise in computational...
TriLink’s CDMO services offer a range of manufacturing grade products from discovery-grade (RUO) to its customizable intermediate-grade - GMPLink™ to full GMP-grade with scale-up and technology transfer expertise. TriLink operates a quality system in compliance with ICH Q7, Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients, Section 19, APIs for Use in Clinical Trials, and ISO 9001:2015 standards. TriLink continues to...
ImmunityBio, Inc. (formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patient’s natural immune system, potentially enabling it to outsmart the disease and eliminate cancerous or infected cells. The activation of the innate immune system is key to the development of immunological memory. Over the last two decades, our founder and Executive Chairman Dr....
Tr1X Inc. (pr. "Trix") is a biotechnology company dedicated to the development of novel cellular immunotherapies for patients with autoimmune and inflammatory diseases. The Company uses its proprietary platform for the generation of first-in-class cell therapy products aimed at rebalancing the immune system and restoring homeostasis, leading to long term tolerance. Tr1X is headquartered in La Jolla, CA.
QXO is a North American building-products distributor and installer. It is the largest distributor and installer of insulation, the second-largest distributor of roofing products, the second-largest publicly traded distributor of lumber and building materials, and the largest distributor of waterproofing products. QXO seeks to become a tech-enabled leader through best-in-class customer satisfaction, accretive acquisitions, and organic growth across North America.
QXO's Top Stability & Growth Strengths
Strong Revenue Growth: Feedback suggests revenue and net sales are expanding rapidly, with large year-over-year increases supported by both acquisitions and improving organic trends.
Innovation-Driven Growth: Feedback suggests a plan to modernize a traditionally low-tech industry through technology, data analytics, and disciplined execution is central to the growth thesis.
Strong Market Position & Advantage: Feedback suggests top-tier rankings in insulation, roofing, and waterproofing, alongside broad geographic scale and a large customer base, underpin competitive standing.
TestEquity is the industry’s largest authorized distributor of test and measurement solutions and production supplies. We stock the most solutions to help you design and build electronics. We understand highly-specialized technology demands highly-personalized service. Together, let’s put innovation to the test. 800-950-3457 www.testequity.com
Ewing is the largest family-owned supplier of landscape and water management products in the country. Ewing offers commercial and residential irrigation supplies, water management solutions, landscape and turf products, hardscapes, landscape lighting, water features, erosion control, industry-leading seminars and more to professionals serving the landscaping, sports turf, golf, agricultural and industrial industries.
Right from the beginning, which is now more than fifty years ago, Bruker has been driven by a single idea: to provide the best technological solution for each analytical task. Today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. Bruker systems cover a broad spectrum of applications in...
Bruker's Top Stability & Growth Strengths
Profitability: Earnings are expanding, with non-GAAP EPS rising strongly and both gross and operating margins improving year over year. Guidance points to further non-GAAP EPS growth despite only modest sales increases.
Cost & Operational Efficiency: Cost discipline is lifting profitability, evidenced by year-over-year improvements in non-GAAP gross and operating margins. Operational focus appears to be a meaningful lever while revenue growth remains subdued.
Strong Market Position & Advantage: The company holds category leadership in areas such as high-field NMR, AFM/nanoanalysis, and superconducting wire, supported by a large installed base. Its specialized positions in proteomics, spatial biology, diagnostics, and semiconductor metrology reinforce competitive differentiation.
Pendulum is committed to developing novel interventions that target the human microbiome to improve the lives of patients suffering from a variety of diseases. Our targeted formulations of natural bacterial strains help to rebalance the microbiome which restores and improve one’s health.
Varda Space Industries was founded in 2020 with the goal of manufacturing products in space to benefit life on Earth. Co-founders Will Bruey and Delian Asparouhov imagined a world where space could be leveraged not only for storytelling and awe, but for its economic benefits. Varda was created as a platform for in-space manufacturing, with a range of real-life, on-Earth...
Tamarind Bio provides an AI-powered computational biology platform and API that gives scientists a simple, scalable interface to drug-discovery tools. Its no-code web platform and API support protein structure prediction, protein and enzyme design, molecular docking, and molecule optimization using models such as AlphaFold. The company serves researchers at pharmaceutical companies, biotech firms, and academic institutions without requiring specialized computing...
.png)
































